Growth Hormone & Thymus Regeneration - Dr. Greg Fahy | Lifespan.IO @LifespanIO
Growth Hormone & Thymus Regeneration - Dr. Greg Fahy | Lifespan.IO  @LifespanIO
Uploaded January 2022 | Updated November 2026, 5 days ago
Dr. Greg Fahy gives an update on the TRIIM-X clinical trial at EARD 2021.

The TRIIM-X clinical trial aims to understand how to create a personalized thymus regeneration regimen. By regenerating the thymus, the researchers hope to be able to prevent or reverse certain aspects of immune system aging.

FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io

DESCRIPTION
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Dr. Fahy holds a Bachelor of Science degree in Biology from the University of California at Irvine and a Ph.D. from the Medical College of Georgia in Augusta. Dr. Fahy used to be the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program for the U.S. Naval Medical Research Institute in Bethesda, Maryland, where he developed the original concept of ice blocking agents.

Dr. Fahy is the Chief Scientific Officer and co-founder of Intervene Immune, a biotech company researching rejuvenation of the immune system, particularly the thymus. He designed and led the TRIIM trial, published the first report of thymus regeneration in a normal human, and granted patents on methods for and applications of human thymus regeneration. Before his time at 21st Century Medicine, where he is the Executive Director and Chief Scientific Officer, Dr. Fahy pioneered the practical use of cryopreservation by vitrification and invented a computer system to apply this technology to organs at the American Red Cross.

Dr. Fahy is also a biogerontologist and is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension, a multi-authored book about the future of biogerontology.
For 16 years, Dr. Fahy worked as a Director of the American Aging Association and for 6 years as the editor of AGE News, the organization’s newsletter. He currently serves on the editorial boards of Rejuvenation Research and the Open Geriatric Medicine Journal.

The annual Ending Age-Related Diseases (EARD) conference by Lifespan.io brings together longevity thought leaders together to exchange research reports, inspire and get inspired with new ideas, find collaborators, supporters, and mentors.

HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero:
lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io

#EARD2021 #Longevity #thymus #thymusregeneration
Growth Hormone & Thymus Regeneration - Dr. Greg Fahy | Lifespan.IOA Synthetic Gene Oscillator to Slow Cellular AgingAlzheimers Not Caused by Amyloid Plaques? New Paper Suggests Different, Related ExplanationWho Wants To Live Forever? | Lifespan News ExtraBecome the CEO of Your Own Health - Kevin Perrott & OpenCuresOptimizing Biologic Age  -  Michael Lustgarten | Lifespan.IOScience and Fiction in the Movie Old: Lifespan.io Film ReviewThe Hyperfunction Theory of AgingHuman Fasting Modulates Macrophage FunctionThe Future of Regenerative Medicine - Greg Grinberg, CEO of ActualFoodRejuvenation Roundup Podcast - October 2022Garri Zmudze at EARD 2022: Funding Impactful and Accessible Longevity R&D
Lifespan Research Institute |

Growth Hormone & Thymus Regeneration - Dr. Greg Fahy | Lifespan.IO

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER